Biostem Technologies (BSEM) closed at $1.13 on November 6, 2026, up 8.7% from the previous close, on volume of 94,359 shares (30-day average 164,640).
Data as of November 6, 2026.
BioStem Updates BR-AC Wound-Healing Study: What BSEM Investors Should Know
TipRanks (Wed, 4-Nov 11:31 AM ET)
Globe Newswire (Thu, 29-Oct 4:05 PM ET)
BioStem Technologies' CEO and COO Invest $1 Million in Cash Through Exercise of Stock Options
Globe Newswire (Thu, 8-Oct 7:00 AM ET)
BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio
Globe Newswire (Thu, 1-Oct 7:00 AM ET)
BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Globe Newswire (Wed, 30-Sep 8:00 AM ET)
Globe Newswire (Mon, 21-Sep 4:30 PM ET)
Market Chameleon (Fri, 18-Sep 6:30 AM ET)
BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility
Globe Newswire (Fri, 18-Sep 7:00 AM ET)
BioStem Technologies Opens Hospital Access for VENDAJE and VENDAJE AC Through Vizient and Premier
Globe Newswire (Fri, 4-Sep 7:00 AM ET)
BioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Globe Newswire (Thu, 3-Sep 4:05 PM ET)
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.
Biostem Technologies trades on the NASDAQ stock market under the symbol BSEM.
As of November 6, 2026, BSEM stock price climbed to $1.13 with 94,359 million shares trading.
BSEM has a beta of -2.48, meaning it tends to be less sensitive to market movements. BSEM has a correlation of 0.02 to the broad based SPY ETF.
BSEM has a market cap of $21.10 million. This is considered a Sub-Micro Cap stock.
The top ETF exchange traded funds that BSEM belongs to (by Net Assets): VTI, VXF.
BSEM support price is $.94 and resistance is $1.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BSEM shares will trade within this expected range on the day.
